Discharge Medications for Acute Gastritis from the Emergency Department
Prescribe a proton pump inhibitor (PPI) for 4-6 weeks as the primary discharge medication for acute gastritis, with consideration for H. pylori testing and eradication therapy if positive.
Primary Pharmacological Management
Acid Suppression Therapy
The cornerstone of discharge treatment is acid suppression with a PPI, which provides robust symptom relief and promotes mucosal healing 1. PPIs are superior to H2-receptor antagonists for gastritis management and should be prescribed for 4-6 weeks initially.
Alternative acid suppression options include:
- H2-receptor antagonists (H2RAs) if PPIs are contraindicated, though they provide less potent acid suppression 1
- Potassium-competitive acid blockers (P-CABs) as a newer alternative offering rapid symptom relief 1
Mucoprotective Agents
Consider adding mucoprotective agents (such as rebamipide or sucralfate) to enhance gastric mucosal protection through promoting regeneration, reducing inflammation, and mitigating oxidative stress 1. These agents have demonstrated effectiveness in promoting endoscopic healing and symptom amelioration in clinical trials.
H. pylori Considerations
Testing Strategy
H. pylori testing in the ED setting is feasible and should be considered for symptomatic patients with acute gastritis 2. Point-of-care urea breath testing can be performed during the ED visit, with a 23% positivity rate demonstrated in ED populations.
Eradication Therapy
If H. pylori testing is positive, prescribe bismuth quadruple therapy (BQT) for 14 days as the preferred empiric regimen 3. This represents the most current guideline recommendation for treatment-naive patients when antibiotic susceptibility is unknown.
For acute H. pylori gastritis specifically, early eradication therapy is highly effective - a 1-week regimen of lansoprazole 30mg once daily + clarithromycin 400mg twice daily + amoxicillin 1000mg twice daily + rebamipide 300mg three times daily achieved 100% cure rates when started within 1 day of symptom onset 4.
Alternative empiric regimens include:
NSAID-Related Gastritis
Medication Discontinuation
Stop all NSAIDs and aspirin if possible 5. This is critical for healing.
If NSAIDs Must Continue
When NSAID continuation is medically necessary:
- Prescribe PPI co-therapy (mandatory) 6, 7
- Switch to the least damaging agent (ibuprofen at lowest effective dose) 5
- Consider COX-2 selective inhibitors (celecoxib) as an alternative 6, 7
For patients with previous GI bleeding who require NSAIDs: prescribe a COX-2 inhibitor PLUS a PPI - this combination provides the safest option 7.
Follow-Up Requirements
Gastric Ulcer Cases
Patients with gastric ulcers require repeat endoscopy at 6 weeks to confirm healing and exclude malignancy 5. Continue PPI therapy until that point.
H. pylori Eradication
All patients treated for H. pylori require test-of-cure 3. However, ED follow-up compliance is challenging - only 47% of patients returned for retesting in one study, though 67% reported medication compliance 2.
Common Pitfalls to Avoid
Do not prescribe NSAIDs alone in patients with gastritis history - always add PPI co-therapy if NSAIDs are necessary 6
Do not use clarithromycin or levofloxacin-based regimens for H. pylori without confirmed antibiotic susceptibility due to rising resistance rates 3
Do not assume duodenal ulcers need endoscopic confirmation of healing after H. pylori eradication, unless the patient continues NSAIDs 5
Do not forget H. pylori eradication in NSAID users - while data are conflicting, many centers advocate eradication therapy even in NSAID-associated ulcers 5
Symptomatic Management
Antiemetics are not routinely indicated for acute gastritis discharge unless significant ongoing nausea/vomiting persists. The evidence for ondansetron relates to gastroenteritis, not gastritis 8.